So the solid cancer market is "no market opportunity", no wonder you invested in RAC lol. CR very early in Ph1 clinical trial with durability of nearly 2 years and numerous SD and PR is terrible......you are new to biotech start-up investment aren't you?????
IMU Price at posting:
3.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)